Is VRDN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 17th of October 2014, Viridian Therapeutics, had a stock price of $776.25. If you invested back then, your return now would be a loss of $-752.47 per share or -96.94%
Yes, the average daily trading liquidity for Viridian Therapeutics, is $22.72 million. You should therefore be able to get in and out of your positions relatively fast.
Viridian Therapeutics, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Viridian Therapeutics, to be medium [0.7 out of 1]